These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 29775273)
1. The Role of ClpP Protease in Bacterial Pathogenesis and Human Diseases. Bhandari V; Wong KS; Zhou JL; Mabanglo MF; Batey RA; Houry WA ACS Chem Biol; 2018 Jun; 13(6):1413-1425. PubMed ID: 29775273 [TBL] [Abstract][Full Text] [Related]
2. ClpP Protease, a Promising Antimicrobial Target. Moreno-Cinos C; Goossens K; Salado IG; Van Der Veken P; De Winter H; Augustyns K Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067645 [TBL] [Abstract][Full Text] [Related]
3. The development of small-molecule modulators for ClpP protease activity. Ye F; Li J; Yang CG Mol Biosyst; 2016 Dec; 13(1):23-31. PubMed ID: 27831584 [TBL] [Abstract][Full Text] [Related]
4. Validation of the essential ClpP protease in Mycobacterium tuberculosis as a novel drug target. Ollinger J; O'Malley T; Kesicki EA; Odingo J; Parish T J Bacteriol; 2012 Feb; 194(3):663-8. PubMed ID: 22123255 [TBL] [Abstract][Full Text] [Related]
5. Bacterial caseinolytic proteases as novel targets for antibacterial treatment. Brötz-Oesterhelt H; Sass P Int J Med Microbiol; 2014 Jan; 304(1):23-30. PubMed ID: 24119566 [TBL] [Abstract][Full Text] [Related]
6. Substrates and interactors of the ClpP protease in the mitochondria. Mabanglo MF; Bhandari V; Houry WA Curr Opin Chem Biol; 2022 Feb; 66():102078. PubMed ID: 34446368 [TBL] [Abstract][Full Text] [Related]
7. Activators of cylindrical proteases as antimicrobials: identification and development of small molecule activators of ClpP protease. Leung E; Datti A; Cossette M; Goodreid J; McCaw SE; Mah M; Nakhamchik A; Ogata K; El Bakkouri M; Cheng YQ; Wodak SJ; Eger BT; Pai EF; Liu J; Gray-Owen S; Batey RA; Houry WA Chem Biol; 2011 Sep; 18(9):1167-78. PubMed ID: 21944755 [TBL] [Abstract][Full Text] [Related]
8. The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease. Kirstein J; Hoffmann A; Lilie H; Schmidt R; Rübsamen-Waigmann H; Brötz-Oesterhelt H; Mogk A; Turgay K EMBO Mol Med; 2009 Apr; 1(1):37-49. PubMed ID: 20049702 [TBL] [Abstract][Full Text] [Related]
9. Acyldepsipeptide antibiotics kill mycobacteria by preventing the physiological functions of the ClpP1P2 protease. Famulla K; Sass P; Malik I; Akopian T; Kandror O; Alber M; Hinzen B; Ruebsamen-Schaeff H; Kalscheuer R; Goldberg AL; Brötz-Oesterhelt H Mol Microbiol; 2016 Jul; 101(2):194-209. PubMed ID: 26919556 [TBL] [Abstract][Full Text] [Related]
10. Identification and Characterization of Approved Drugs and Drug-Like Compounds as Covalent Sassetti E; Durante Cruz C; Tammela P; Winterhalter M; Augustyns K; Gribbon P; Windshügel B Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159170 [TBL] [Abstract][Full Text] [Related]
11. The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1. Leodolter J; Warweg J; Weber-Ban E PLoS One; 2015; 10(5):e0125345. PubMed ID: 25933022 [TBL] [Abstract][Full Text] [Related]
12. Two ways to skin a cat: acyldepsipeptides antibiotics can kill bacteria through activation or inhibition of ClpP activity. Vass RH; Chien P Mol Microbiol; 2016 Jul; 101(2):183-5. PubMed ID: 27000447 [TBL] [Abstract][Full Text] [Related]
13. α-Amino Diphenyl Phosphonates as Novel Inhibitors of Escherichia coli ClpP Protease. Moreno-Cinos C; Sassetti E; Salado IG; Witt G; Benramdane S; Reinhardt L; Cruz CD; Joossens J; Van der Veken P; Brötz-Oesterhelt H; Tammela P; Winterhalter M; Gribbon P; Windshügel B; Augustyns K J Med Chem; 2019 Jan; 62(2):774-797. PubMed ID: 30571121 [TBL] [Abstract][Full Text] [Related]
14. The ClpP peptidase of Wolbachia endobacteria is a novel target for drug development against filarial infections. Schiefer A; Vollmer J; Lämmer C; Specht S; Lentz C; Ruebsamen-Schaeff H; Brötz-Oesterhelt H; Hoerauf A; Pfarr K J Antimicrob Chemother; 2013 Aug; 68(8):1790-800. PubMed ID: 23584755 [TBL] [Abstract][Full Text] [Related]
15. Acyldepsipeptide Analogs Dysregulate Human Mitochondrial ClpP Protease Activity and Cause Apoptotic Cell Death. Wong KS; Mabanglo MF; Seraphim TV; Mollica A; Mao YQ; Rizzolo K; Leung E; Moutaoufik MT; Hoell L; Phanse S; Goodreid J; Barbosa LRS; Ramos CHI; Babu M; Mennella V; Batey RA; Schimmer AD; Houry WA Cell Chem Biol; 2018 Aug; 25(8):1017-1030.e9. PubMed ID: 30126533 [TBL] [Abstract][Full Text] [Related]
16. The ATP-Dependent Protease ClpP Inhibits Biofilm Formation by Regulating Agr and Cell Wall Hydrolase Sle1 in Liu Q; Wang X; Qin J; Cheng S; Yeo WS; He L; Ma X; Liu X; Li M; Bae T Front Cell Infect Microbiol; 2017; 7():181. PubMed ID: 28555174 [TBL] [Abstract][Full Text] [Related]
17. ClpP Peptidase as a Plausible Target for the Discovery of Novel Antibiotics. Bhardwaj S; Roy KK Curr Drug Targets; 2024; 25(2):108-120. PubMed ID: 38151841 [TBL] [Abstract][Full Text] [Related]
18. Imipridone Anticancer Compounds Ectopically Activate the ClpP Protease and Represent a New Scaffold for Antibiotic Development. Jacques S; van der Sloot AM; C Huard C; Coulombe-Huntington J; Tsao S; Tollis S; Bertomeu T; Culp EJ; Pallant D; Cook MA; Bonneil E; Thibault P; Wright GD; Tyers M Genetics; 2020 Apr; 214(4):1103-1120. PubMed ID: 32094149 [TBL] [Abstract][Full Text] [Related]
19. Perrault syndrome type 3 caused by diverse molecular defects in CLPP. Brodie EJ; Zhan H; Saiyed T; Truscott KN; Dougan DA Sci Rep; 2018 Aug; 8(1):12862. PubMed ID: 30150665 [TBL] [Abstract][Full Text] [Related]
20. Development and characterization of improved β-lactone-based anti-virulence drugs targeting ClpP. Zeiler E; Korotkov VS; Lorenz-Baath K; Böttcher T; Sieber SA Bioorg Med Chem; 2012 Jan; 20(2):583-91. PubMed ID: 21855356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]